NCT06646055 2026-03-09AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic CancerAkesoPhase 1/2 Active not recruiting110 enrolled
NCT05630183 2025-11-13A Study of Botensilimab in Participants With Metastatic Pancreatic CancerAgenus Inc.Phase 2 Active not recruiting81 enrolled